as on November 27, 2025 at 2:29 am IST
Day's Low
Day's High
2.00%
Downside
1.75%
Upside
52 Week's Low
52 Week's High
77.87%
Downside
4.24%
Upside
Check Relay Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.4B
EPS (TTM)
-1.726
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-2.8
Industry PE ratio
-0.4356168831168831
PEG Ratio
0EBITDA
-320.5M
Revenue (TTM)
8.4M
Profit Margin
0.00%
Return On Equity TTM
-41.15%
Track how Relay Therapeutics Inc P/E has moved over time to understand its valuation trends.
Relay Therapeutics Inc in the last 5 years
Lowest (-13.85x)
June 30, 2021
Today (-2.80x)
November 28, 2025
Industry (-0.44x)
November 28, 2025
Highest (-1.53x)
June 30, 2025
Today’s Price to Earnings Ratio: -2.80x
Compare market cap, revenue, PE, and other key metrics of Relay Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.4B | -84.61% | -2.8 | 0.00% | |
| BUY | $43.6B | 413.84% | -16.34 | -264.83% | |
| BUY | $58.8B | 242.77% | 1435.87 | 1.36% | |
| BUY | $110.8B | 90.63% | 30.22 | 31.35% | |
| BUY | $83.2B | 52.63% | 18.87 | 32.13% |
The Relay Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Relay Therapeutics Inc investment value today
Current value as on today
₹1,73,025
Returns
₹73,025
(+73.03%)
Returns from Relay Therapeutics Inc Stock
₹67,083 (+67.08%)
Dollar Returns*
₹5,942 (+5.94%)
Based on 18 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 18 analysts, 83.33% of analysts recommend a 'BUY' rating for Relay Therapeutics Inc. Average target price of $13.9
Get share price movements and forecasts by analysts on Relay Therapeutics Inc.
What analysts predicted
42.3%UPSIDE
Target Price
$13.9
Current Price
$8.02
Analyzed by
18 Analysts
Target
$13.90
Relay Therapeutics Inc target price $13.9, a slight upside of 42.3% compared to current price of $8.02. According to 18 analysts rating.
Search interest for Relay Therapeutics Inc Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:6% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, RLAY stock has moved up by 18.6%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1006.1% return, outperforming this stock by 1062.5%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.5% return, outperforming this stock by 102.2%
Profit Down
![]()
Netprofit is down for the last 2 quarters, -70.37M → -74.14M (in $), with an average decrease of 5.4% per quarter
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 10.00M → 677.0K (in $), with an average decrease of 57.2% per quarter
| Organisation | Relay Therapeutics Inc |
| Headquarters | 399 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Thomas Catinazzo | Chief Financial Officer |
Dr. Donald A. Bergstrom M.D., Ph.D. | President of Research & Development |
Mr. Jim Watters Ph.D. | Chief Scientific Officer |
Dr. David Elliot Shaw Ph.D. | Founder |
Dr. Matthew P. Jacobson Ph.D. | Founder |
Ms. Soo-Yeun Lim | Senior VP & General Counsel |
Dr. Mahesh Padval Ph.D. | Chief Pharmaceutical Development Officer |
Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS | CEO, President & Director |
Mr. Peter Rahmer | Chief Corporate Development Officer |
Ms. Dorothee Kern Ph.D. | Founder |
Relay Therapeutics Inc share price today is $8.02 as on at the close of the market. Relay Therapeutics Inc share today touched a day high of $8.16 and a low of $7.86.
Relay Therapeutics Inc share touched a 52 week high of $8.36 on and a 52 week low of $1.78 on . Relay Therapeutics Inc stock price today i.e. is closed at $8.02,which is 4.07% down from its 52 week high and 351.83% up from its 52 week low.
Relay Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Relay Therapeutics Inc (RLAY) shares with as little as ₹89.436 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹894.36 in Relay Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Relay Therapeutics Inc share’s latest price of $8.02 as on November 27, 2025 at 2:29 am IST, you will get 1.2469 shares of Relay Therapeutics Inc. Learn more about
fractional shares .
Relay Therapeutics Inc stock has given -84.61% share price returns and 20.58% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?